首页> 美国卫生研究院文献>OncoTargets and therapy >VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody

【2h】

VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody

机译：VEGF是胃癌腹膜转移和恶性腹水的靶分子：VEGF在腹水中的预后意义和抗VEGF单克隆抗体的功效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundIn gastric cancer, poor prognosis is associated with peritoneal dissemination, which often accompanies malignant ascites. We searched for a target molecule in peritoneal metastasis and investigated its clinical utility as a biomarker.

机译：背景在胃癌中，不良的预后与腹膜播散有关，腹膜播散常伴有恶性腹水。我们在腹膜转移中寻找靶分子，并研究其作为生物标志物的临床用途。

著录项

期刊名称 OncoTargets and therapy
作者
Sachio Fushida; Katsunobu Oyama; Jun Kinoshita; Yasumichi Yagi; Kouichi Okamoto; Hidehiro Tajima; Itasu Ninomiya; Takashi Fujimura; Tetsuo Ohta;
展开▼
作者单位

展开▼
年(卷),期 2013(6),-1
年度 2013
页码 1445–1451
总页数 7
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
vascular endothelial growth factor malignant ascites peritoneal metastasis gastric cancer bevacizumab;

机译：血管内皮生长因子;恶性腹水;腹膜转移;胃癌;贝伐单抗;

相似文献

外文文献
中文文献
专利

1. VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody [J] . Sachio Fushida, Katsunobu Oyama, Jun Kinoshita, OncoTargets and therapy . 2013,第3期

机译：VEGF是胃癌腹膜转移和恶性腹水的靶分子：VEGF在腹水中的预后意义和抗VEGF单克隆抗体的功效
2. Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice. [J] . Yagi Y, Fushida S, Harada S, Cancer chemotherapy and pharmacology. . 2010,第4期

机译：人源化抗VEGF单克隆抗体/贝伐单抗在小鼠胃癌皮下异种移植的腹膜转移模型中的生物分布。
3. Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice [J] . Yasumichi Yagi, Sachio Fushida, Shinichi Harada, Cancer Chemotherapy and Pharmacology . 2010,第4期

机译：人源化抗VEGF单克隆抗体/贝伐单抗在胃癌皮下异种移植小鼠腹膜转移模型中的生物分布
4. Measurement of Fc-Mediated ADCC and CDC Activity of Anti-TNFα and Anti-VEGF Therapeutic Antibodies Using Reporter-Based Bioassays and Engineered TNFα+ and VEGF+ Target Cells [C] . Hetal Marble, Denise Garvin, Jamison Grailer, Protein Engineering Summit. . 2018

机译：使用基于报道的生物测定和工程化TNFα+和VEGF +靶细胞测量抗TNFα和抗VEGF治疗抗体的FC介导的ADCC和CDC活性的测量
5. Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: A systemic review and meta-analysis [O] . Ling-Nan Zheng, Feng Wen, Ping Xu, 2019

机译：恶性腹水在胃癌腹膜转移患者中的预后意义：系统评价和荟萃分析
6. VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: Prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody [O] . Fushida, Sachio, Oyama, Katsunobu, Kinoshita, Jun, 2013

机译：VEGF是胃癌腹膜转移和恶性腹水的靶分子：VEGF在腹水中的预后意义及抗VEGF单克隆抗体的疗效

VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody

摘要

著录项

相似文献

相关主题

期刊订阅